Watch the On-Demand Webinar: Advancing Cancer Vaccines
Advancing Cancer Vaccines With New Research and Developments
Cancer vaccines target unique antigens on tumors, including over-expressed healthy proteins or virus-derived proteins. Each individual tumor is unique, carrying its own distinguishing antigens, which can complicate the cancer vaccine development process. To better characterize, identify, and understand the dynamic interactions between the immune system and cancer cell antigens, researchers can turn to advanced flow cytometry and live-cell imaging technologies.
This expert webinar, brought to you by Sartorius, presents new research and developments in the cancer vaccine field, and delves into the intricacies of target discovery and vaccine development.
- Developing breast cancer vaccines with dendritic cell tumor fusions
- Boosting immunity with cancer vaccines: A focus on breast and ovarian cancer immunology.
Learn more about Sartorius solutions for Discovery of Viral Vaccines & Vectors at www.sartorius.com/vaccine-discovery
David E. Avigan, MD
Professor of Medicine
Beth Israel Deaconess Medical Center
Mary L. (Nora) Disis, MD
Helen B. Slonaker Endowed Professor for Cancer Research
American Cancer Society Clinical Research Professor
Professor, Medicine, Adjunct Professor Pathology and Obstetrics and Gynecology, University of Washington
Director, UW Medicine Cancer Vaccine Institute